212 related articles for article (PubMed ID: 15537880)
1. Role of neurokinin 3 receptors in supraoptic vasopressin and oxytocin neurons.
Howe HE; Somponpun SJ; Sladek CD
J Neurosci; 2004 Nov; 24(45):10103-10. PubMed ID: 15537880
[TBL] [Abstract][Full Text] [Related]
2. Blockade of NK3R signaling in the PVN decreases vasopressin and oxytocin release and c-Fos expression in the magnocellular neurons in response to hypotension.
Haley GE; Flynn FW
Am J Physiol Regul Integr Comp Physiol; 2008 Oct; 295(4):R1158-67. PubMed ID: 18650316
[TBL] [Abstract][Full Text] [Related]
3. Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII.
Broccardo M; Improta G; Tabacco A
Eur J Pharmacol; 1999 Jul; 376(1-2):67-71. PubMed ID: 10440091
[TBL] [Abstract][Full Text] [Related]
4. Central neurokinin 3 receptors increase systemic oxytocin release: interaction with norepinephrine.
Bealer SL; Flynn FW
Exp Neurol; 2003 Dec; 184(2):1027-33. PubMed ID: 14769397
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo characterization of NK3 receptors in the rabbit eye by use of selective non-peptide NK3 receptor antagonists.
Medhurst AD; Hay DW; Parsons AA; Martin LD; Griswold DE
Br J Pharmacol; 1997 Oct; 122(3):469-76. PubMed ID: 9351503
[TBL] [Abstract][Full Text] [Related]
6. A Direct Neurokinin B Projection from the Arcuate Nucleus Regulates Magnocellular Vasopressin Cells of the Supraoptic Nucleus.
Pineda R; Sabatier N; Ludwig M; Millar RP; Leng G
J Neuroendocrinol; 2016 Apr; 28(4):. PubMed ID: 26610724
[TBL] [Abstract][Full Text] [Related]
7. Neurokinin-3 peptide instead of neurokinin-1 synergistically exacerbates kainic acid-inducing degeneration of neurons in the substantia nigra of mice.
Chen LW; Wang YQ; Bian GL; Wei LC; Yung KL
J Neurochem; 2008 Apr; 105(1):203-16. PubMed ID: 18021294
[TBL] [Abstract][Full Text] [Related]
8. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
[TBL] [Abstract][Full Text] [Related]
9. Estrogen-dependent regulation of neurokinin 3 receptor-mediated uterine contractility in the rat.
Crane LH; Williams MJ; Nimmo AJ; Hamlin GP
Biol Reprod; 2002 Nov; 67(5):1480-7. PubMed ID: 12390879
[TBL] [Abstract][Full Text] [Related]
10. Neurokinin-receptor-mediated depolarization of cortical neurons elicits an increase in glutamate release at excitatory synapses.
Stacey AE; Woodhall GL; Jones RS
Eur J Neurosci; 2002 Nov; 16(10):1896-906. PubMed ID: 12453053
[TBL] [Abstract][Full Text] [Related]
11. Tachykinin NK3 receptor contribution to systemic release of vasopressin and oxytocin in response to osmotic and hypotensive challenge.
Haley GE; Flynn FW
Am J Physiol Regul Integr Comp Physiol; 2007 Aug; 293(2):R931-7. PubMed ID: 17522129
[TBL] [Abstract][Full Text] [Related]
12. The neurokinin-3 receptor (NK3R) antagonist SB222200 prevents the apomorphine-evoked surface but not nuclear NK3R redistribution in dopaminergic neurons of the rat ventral tegmental area.
Hether S; Misono K; Lessard A
Neuroscience; 2013 Sep; 247():12-24. PubMed ID: 23673279
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of functionally identified and immunohistochemically identified NK(1) receptors on sympathetic neurons.
Jobling P; Messenger JP; Gibbins IL
J Neurophysiol; 2001 May; 85(5):1888-98. PubMed ID: 11353005
[TBL] [Abstract][Full Text] [Related]
14. Central injection of senktide, an NK3 receptor agonist, or neuropeptide Y inhibits LH secretion and induces different patterns of Fos expression in the rat hypothalamus.
Sandoval-Guzmán T; Rance NE
Brain Res; 2004 Nov; 1026(2):307-12. PubMed ID: 15488494
[TBL] [Abstract][Full Text] [Related]
15. Intracerebroventricular injection of senktide-induced Fos expression in vasopressin-containing hypothalamic neurons in the rat.
Ding YD; Shi J; Su LY; Xu JQ; Su CJ; Guo XE; Ju G
Brain Res; 2000 Nov; 882(1-2):95-102. PubMed ID: 11056188
[TBL] [Abstract][Full Text] [Related]
16. Neurokinin B/NK3 receptors exert feedback inhibition on L-DOPA actions in the 6-OHDA lesion rat model of Parkinson's disease.
Zhang X; Andren PE; Chergui K; Svenningsson P
Neuropharmacology; 2008 Jun; 54(7):1143-52. PubMed ID: 18423776
[TBL] [Abstract][Full Text] [Related]
17. Agonist and hypertonic saline-induced trafficking of the NK3-receptors on vasopressin neurons within the paraventricular nucleus of the hypothalamus.
Haley GE; Flynn FW
Am J Physiol Regul Integr Comp Physiol; 2006 May; 290(5):R1242-50. PubMed ID: 16357093
[TBL] [Abstract][Full Text] [Related]
18. Role of non-NMDA receptors in vasopressin and oxytocin release from rat hypothalamo-neurohypophysial explants.
Morsette DJ; Sidorowicz H; Sladek CD
Am J Physiol Regul Integr Comp Physiol; 2001 Feb; 280(2):R313-22. PubMed ID: 11208557
[TBL] [Abstract][Full Text] [Related]
19. Localization of Fos-like immunoreactivity induced by the NK3 tachykinin receptor agonist, senktide, in the guinea-pig brain.
Yip J; Chahl LA
Br J Pharmacol; 1997 Oct; 122(4):715-25. PubMed ID: 9375969
[TBL] [Abstract][Full Text] [Related]
20. NK3 receptor blockade prevents hyperalgesia and the associated spinal cord substance P release in monoarthritic rats.
Zaratin P; Angelici O; Clarke GD; Schmid G; Raiteri M; Carità F; Bonanno G
Neuropharmacology; 2000; 39(1):141-9. PubMed ID: 10665827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
